Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Office Dust

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 1/2 (1)

Trial Status

Not Yet Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07481331Not Yet Recruiting

Creation of a Scale for Assessing Pain and Discomfort in Extremely Premature Infants (EDEX) Hospitalised in Neonatal Intensive Care, Inspired by the Early Infant Pain and Discomfort Scale (EDIN)

NCT00143637Phase 1/2CompletedPrimary

Dose Response Relations for Health Effects Caused by Office Dust

Showing all 2 trials

Research Network

Common Treatments

  • Office Dust1
  • Clean Air1

Active Sponsors

  • University of Aarhus1
  • The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)1
  • Centre Hospitalier Universitaire de la Réunion1
  • Service Branchens Arbejdsgiverforening i Danmark1

Top Investigators

  • Fleur BRIGNANO1

    University Hospital Centre of Reunion Island

  • Lars Mølhave, DMSc, Ph.D.1

    The Air Pollution Unit, Department of Environmental and Occupational Medicine, Institute of Public Health, The University of Aarhus.

Related Conditions

  • Changed Lung Function1
  • Extremely Premature Infant1
  • Pain1

Activity Timeline